No Data
No Data
No Data
No Data
No Data
Gelonghui Announcements Selected | Mindray Healthcare: Net profit increased 22.9% to 3.16 billion yuan in the first quarter, and all three major international business lines achieved rapid growth; Yunnan Baiyao: Net profit of 1.702 billion yuan in the fir
[Performance data] Sanan Optoelectronics (600703.SH): Net profit of 367 million yuan in 2023, and plans to distribute 0.3 yuan Sanan Optoelectronics (600703.SH) to release the 2023 annual report, achieving operating income of 14.53 billion yuan, an increase of 6.28%; net profit attributable to shareholders of listed companies was 367 million yuan, a year-on-year decrease of 46.50%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - $1,088 million, with basic earnings per share of 0.07 yuan. It is proposed to distribute a cash dividend of 0.30 yuan (tax included) for every 10 shares to all shareholders. Changsha silver
Gelonghui FinanceApr 26 11:22 ET
The third generation of medicine has lost 150 billion
Growth is still ongoing
Gelonghui FinanceApr 21 05:23 ET
North and South Water | Beishui made a significant net purchase of nearly HK$10 billion, increasing CNPC's inventory for 5 consecutive days; Nanshui raised more than 200 million yuan from Maotai
Track the latest developments in north-south funding
Gelonghui FinanceApr 16 06:13 ET
The Total Return for Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on a lighter note, a good company can see its share price rise well over
Simply Wall StApr 13 20:21 ET
Guoxin Securities: The pharmaceutical industry is entering an upward inflection point in the medium to long term, and focus on high growth targets in the quarterly report in the short term
The pharmaceutical industry currently has low growth, low profitability, undervaluation, and low transaction attention, and is entering a major layout range at an upward inflection point in the medium to long term.
Zhitong FinanceMar 28 02:48 ET
Here's What Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Strong Returns On Capital Mean
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in con
Simply Wall StMar 26 20:13 ET
No Data
No Data